# Ultragenyx Pharmaceutical Inc.: Form 8-K, filed Aug 11, 2026

- Company: [Ultragenyx Pharmaceutical Inc.](/companies/rare.md) (CIK 1515673)
- Form: 8-K
- Filed: 2026-08-11
- Accepted by EDGAR: Aug 11, 2026, 08:30 ET
- Period: 2026-08-07
- Accession: 0001193125-26-343525
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1515673/000119312526343525/rare-20260807.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1515673/000119312526343525/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1515673/000119312526343525/rare-20260807.htm

Filed Aug 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-343525. Last ingested by Listed: Nov 14, 2026, 11:37 ET. No prices; not investment advice.
